Division of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, Washington, 98109, USA.
Molecular and Cellular Biology Program, 1959 NE Pacific Street, HSB T-466, University of Washington, Box 357275, Seattle, WA, 98195-7275, USA.
Sci Rep. 2017 Sep 7;7(1):10838. doi: 10.1038/s41598-017-11040-3.
Suppressors of cytokine signaling (SOCS) proteins inhibit signaling by serving as substrate receptors for the Cullin5-RING E3 ubiquitin ligase (CRL5) and through a variety of CRL5-independent mechanisms. CRL5, SOCS2 and SOCS6 are implicated in suppressing transformation of epithelial cells. We identified cell proteins that interact with SOCS2 and SOCS6 using two parallel proteomics techniques: BioID and Flag affinity purification mass spectrometry. The receptor tyrosine kinase ephrin type-A receptor 2 (EphA2) was identified as a SOCS2-interacting protein. SOCS2-EphA2 binding requires the SOCS2 SH2 domain and EphA2 activation loop autophosphorylation, which is stimulated by Ephrin A1 (EfnA1) or by phosphotyrosine phosphatase inhibition. Surprisingly, EfnA1-stimulated EphA2-SOCS2 binding is delayed until EphA2 has been internalized into endosomes. This suggests that SOCS2 binds to EphA2 in the context of endosomal membranes. We also found that SOCS2 overexpression decreases steady state levels of EphA2, consistent with increased EphA2 degradation. This effect is indirect: SOCS2 induces EfnA1 expression, and EfnA1 induces EphA2 down-regulation. Other RTKs have been reported to bind, and be regulated by, over-expressed SOCS proteins. Our data suggest that SOCS protein over-expression may regulate receptor tyrosine kinases through indirect and direct mechanisms.
细胞因子信号转导抑制蛋白 (SOCS) 作为 Cullin5-RING E3 泛素连接酶 (CRL5) 的底物受体,并通过多种 CRL5 非依赖性机制抑制信号转导。CRL5、SOCS2 和 SOCS6 参与抑制上皮细胞的转化。我们使用两种平行的蛋白质组学技术:BioID 和 Flag 亲和纯化质谱法,鉴定与 SOCS2 和 SOCS6 相互作用的细胞蛋白。受体酪氨酸激酶 Ephrin 型-A 受体 2 (EphA2) 被鉴定为 SOCS2 相互作用蛋白。SOCS2-EphA2 结合需要 SOCS2 SH2 结构域和 EphA2 激活环自身磷酸化,这由 Ephrin A1 (EfnA1) 或磷酸酪氨酸磷酸酶抑制所刺激。令人惊讶的是,EfnA1 刺激的 EphA2-SOCS2 结合延迟到 EphA2 被内化到内体中。这表明 SOCS2 在内体膜的背景下与 EphA2 结合。我们还发现,SOCS2 过表达降低 EphA2 的稳态水平,与 EphA2 降解增加一致。这种效应是间接的:SOCS2 诱导 EfnA1 表达,EfnA1 诱导 EphA2 下调。其他 RTKs 已被报道与过表达的 SOCS 蛋白结合并受其调节。我们的数据表明,SOCS 蛋白过表达可能通过间接和直接机制调节受体酪氨酸激酶。